women's health
Roche Preeclampsia Assay Nabs FDA 510(k) Clearance
The prognostic test stratifies hospitalized women with hypertensive disorders of pregnancy into low- and high-risk categories for developing severe preeclampsia.
Nanopath Nabs $3M SBIR Grant for Pelvic, Gynecologic Infection Tests
The National Institutes of Health funding and $1 million awarded in September from the National Science Foundation will support the firm's R&D.
Craig-Hallum Initiates Coverage of Natera With Buy Rating
Analyst Bill Bonello noted growth potential across Natera's markets, along with potential risks related to reimbursement, competition, and profitability.
Natera pointed to expanded Signatera coverage, the upcoming completion of its ALTAIR study, and potential uplift from recent biomarker legislation as future growth drivers.
The Foundation for the National Institutes of Health is leading a public-private collaboration that could help make available in the US tests that are sold in Europe.